MH-910
Fatty acid oxidation disorders
A medicine under regulatory review in the European Union for a selected fatty acid oxidation disorder, with orphan designation previously granted.
- Indication
- Selected fatty acid oxidation indication
- Patient population
- Paediatric patients
- Regulatory status
- EU regulatory submission under review
- Geography
- United Kingdom · European Union
- Partner status
- Wholly owned
Under regulatory review. Subject to regulatory decision; not yet approved for marketing.
